Fig. 1.
IL-10 inhibits the tumorigenicity of DG75 sublines.
The 107 cells from wild-type (WT) as well as vector control, hIL-10–, and vIL-10–transfected sublines were injected sc into SCID mice (A), or antiasialoGM1-treated SCID mice (B). The combined results of 6 independent experiments are shown.
